Noninfectious Granulomatous Diseases: An Update

Advances in Dermatology

Volumn 22, Issue , 2006, Pages 31-53

  Izikson, Leonid ^a   English III, Joseph C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOMA; GRANULOMA ANNULARE; HUMAN; NECROBIOSIS LIPOIDICA; REVIEW; RHEUMATOID NODULE; SARCOIDOSIS; SKIN DISEASE;

GRANULOMA; GRANULOMA ANNULARE; HUMANS; NECROBIOSIS LIPOIDICA; RHEUMATOID NODULE; SARCOIDOSIS; SKIN DISEASES;

EID: 33845803652     PISSN: 08820880     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yadr.2006.09.005     Document Type: Review

References (101)

1. Sayah A., and English III J.C. Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol 53 (2005) 191-209
2. Tomasini C., and Pippione M. Interstitial granulomatous dermatitis with plaques. J Am Acad Dermatol 46 (2002) 892-899
3. Aloi F., Tomasini C., and Pippione M. Interstitial granulomatous dermatitis with plaques. Am J Dermatopathol 21 (1999) 320-323
4. Verneuil L., Dompmartin A., Comoz F., et al. Interstitial granulomatous dermatitis with cutaneous cords and arthritis: a disorder associated with autoantibodies. J Am Acad Dermatol 45 (2001) 286-291
5. Banuls J., Betlloch I., Botella R., et al. Interstitial granulomatous dermatitis with plaques and arthritis. Eur J Dermatol 13 (2003) 308-310
6. Long D., Thiboutot D.M., Majeski J.T., et al. Interstitial granulomatous dermatitis with arthritis. J Am Acad Dermatol 34 (1996) 957-961
7. Schreckenberg C., Asch P.H., Sibilia J., et al. Interstitial granulomatous dermatitis and paraneoplastic rheumatoid polyarthritis disclosing cancer of the lung. Ann Dermatol Venereol 125 (1998) 585-588
8. Lee H.W., Chang S.E., Lee M.W., et al. Interstitial granulomatous dermatitis with plaques associated with antiphospholipid syndrome. Br J Dermatol 152 (2005) 814-816
9. Magro C.M., Crowson A.N., and Schapiro B.L. The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity. J Cutan Pathol 25 (1998) 72-78
10. Dyson S.W., Hirsch A., and Jaworsky C. Interstitial granulomatous dermatitis secondary to soy. J Am Acad Dermatol 51 (2004) S105-S107
11. DiCaudo D.J., and Connolly S.M. Interstitial granulomatous dermatitis associated with pulmonary coccidioidomycosis. J Am Acad Dermatol 45 (2001) 840-845
12. Scherbenske J.M., Benson P.M., Lupton G.P., et al. Rheumatoid neutrophilic dermatitis. Arch Dermatol 125 (1989) 1105-1108
13. Wu H., Barusevicius A., and Lessin S.R. Granuloma annulare with a mycosis fungoides-like distribution and palisaded granulomas of CD68-positive histiocytes. J Am Acad Dermatol 51 (2004) 39-44
14. Mutasim D.F., and Bridges A.G. Patch granuloma annulare: clinicopathologic study of 6 patients. J Am Acad Dermatol 42 (2000) 417-421
15. Takiwaki H., Adachi A., Kohno H., et al. Intravascular or intralymphatic histiocytosis associated with rheumatoid arthritis: a report of 4 cases. J Am Acad Dermatol 50 (2004) 585-590
16. Lee H.W., Yun W.J., Lee M.W., et al. Interstitial granulomatous drug reaction caused by Chinese herbal medication. J Am Acad Dermatol 52 (2005) 712-713
17. Lim A.C., Hart K., and Murrell D. A granuloma annulare-like eruption associated with the use of amlodipine. Australas J Dermatol 43 (2002) 24-27
18. Ball R.A., Kinchelow T., and ISR Substudy Group. Injection site reactions with the HIV-1 fusion inhibitor enfuvirtide. J Am Acad Dermatol 49 (2003) 826-831
19. Sangueza O.P., Caudell M.D., Mengesha Y.M., et al. Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis. J Am Acad Dermatol 47 (2002) 251-257
20. Magro C.M., and Crowson A.N. Lichenoid and granulomatous dermatitis. Int J Dermatol 39 (2000) 126-133
21. Magro C.M., and Crowson A.N. The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. J Cutan Pathol 30 (2003) 1-10
22. English III J.C., Patel P.J., and Greer K.E. Sarcoidosis. J Am Acad Dermatol 44 (2001) 725-743
23. Baughman R.P., Lower E.E., and du Bois R.M. Sarcoidosis. Lancet 361 (2003) 1111-1118
24. Ishige I., Usui Y., Takemura T., et al. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 354 (1999) 120-123
25. Ebe Y., Ikushima S., Yamaguchi T., et al. Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 17 (2000) 256-265
26. Hurst E.A., and Mauro T. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature. Arch Dermatol 141 7 (2005) 865-868
27. Ramos-Casals M., Mana J., Nardi N., et al. HISPAMEC Study Group. Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases. Medicine (Baltimore) 84 (2005) 69-80
28. Tsimpoukas F., Goritsas C., Papadopoulos N., et al. Sarcoidosis in untreated chronic hepatitis C virus infection. Scand J Gastroenterol 39 (2004) 401-403
29. Marcoval J., Moreno A., and Mana J. Papular sarcoidosis of the knees: a clue for the diagnosis of erythema nodosum-associated sarcoidosis. J Am Acad Dermatol 49 (2003) 75-78
30. Dal Sacco D., Cozzani E., Parodi A., et al. Scar sarcoidosis after hyaluronic acid injection. Int J Dermatol 44 (2005) 411-412
31. Marcoval J., Mana J., Moreno A., et al. Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis. Arch Dermatol 137 4 (2001) 427-430
32. Walsh N.M., Hanly J.G., Tremaine R., et al. Cutaneous sarcoidosis and foreign bodies. Am J Dermatopathol 15 (1993) 203-207
33. Kim Y.C., Triffet M.K., and Gibson L.E. Foreign bodies in sarcoidosis. Am J Dermatopathol 22 (2000) 408-412
34. Papageorgiou P.P., Hongcharu W., and Chu A.C. Systemic sarcoidosis presenting with multiple tattoo granulomas and an extra-tattoo cutaneous granuloma. J Eur Acad Dermatol Venereol 12 (1999) 51-53
35. Jones M.S., Maloney M.E., and Helm K.F. Systemic sarcoidosis presenting in the black dye of a tattoo. Cutis 59 (1997) 113-115
36. Antonovich D.D., and Callen J.P. Development of sarcoidosis in cosmetic tattoos. Arch Dermatol 141 (2005) 869-872
37. Ball N.J., Kho G.T., and Martinka M. The histologic spectrum of cutaneous sarcoidosis: a study of twenty-eight cases. J Cutan Pathol 31 (2004) 160-168
38. Bachelez H., Senet P., Cadranel J., et al. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137 (2001) 69-73
39. Haley H., Cantrell W., and Smith K. Infliximab therapy for sarcoidosis (lupus pernio). Br J Dermatol 150 (2004) 146-149
40. Mallbris L., Ljungberg A., Hedblad M.A., et al. Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy. J Am Acad Dermatol 48 (2003) 290-293
41. Heffernan M.P., and Anadkat M.J. Recalcitrant cutaneous sarcoidosis responding to infliximab. Arch Dermatol 141 (2005) 910-911
42. Meyerle J.H., and Shorr A. The use of infliximab in cutaneous sarcoidosis. J Drugs Dermatol 2 (2003) 413-414
43. Khanna D., Liebling M.R., and Louie J.S. Etanercept ameliorates sarcoidosis arthritis and skin disease. J Rheumatol 30 (2003) 1864-1867
44. Dabski K., and Winkelmann R.K. Generalized granuloma annulare: clinical and laboratory findings in 100 patients. J Am Acad Dermatol 20 (1989) 39-47
45. Li A., Hogan D.J., Sanusi I.D., et al. Granuloma annulare and malignant neoplasms. Am J Dermatopathol 25 (2003) 113-116
46. Smith M.D., Downie J.B., and DiCostanzo D. Granuloma annulare. Int J Dermatol 36 (1997) 326-333
47. Studer E.M., Calza A.M., and Saurat J.H. Precipitating factors and associated diseases in 84 patients with granuloma annulare: a retrospective study. Dermatology 193 4 (1996) 364-368
48. Muhlemann M.F., and Williams D.R. Localized granuloma annulare is associated with insulin-dependent diabetes mellitus. Br J Dermatol 111 (1984) 325-329
49. Kidd G.S., Graff G.E., Davies B.F., et al. Glucose tolerance in granuloma annulare. Diabetes Care 8 (1985) 380-384
50. Grogg K.L., and Nascimento A.G. Subcutaneous granuloma annulare in childhood: clinicopathologic features in 34 cases. Pediatrics 107 (2001) E42
51. Fayyazi A., Schweyer S., Eichmeyer B., et al. Expression of IFNgamma, coexpression of TNFalpha and matrix metalloproteinases and apoptosis of T lymphocytes and macrophages in granuloma annulare. Arch Dermatol Res 292 (2000) 384-390
52. Pasmatzi E., Georgiou S., Monastirli A., et al. Temporary remission of disseminated granuloma annulare under oral isotretinoin therapy. Int J Dermatol 44 (2005) 169-171
53. Arroyo M.P. Generalized granuloma annulare. Dermatol Online J 9 (2003) 13
54. Bakos L., Hampe S., da Rocha J.L., et al. Generalized granuloma annulare in a patient with acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol 17 (1987) 844-845
55. Leenutaphong V., Holzle E., Erckenbrecht J., et al. Remission of human immunodeficiency virus-associated generalized granuloma annulare under zidovudine therapy. J Am Acad Dermatol 19 (1988) 1126-1127
56. Huerter C.J., Bass J., Bergfeld W.F., et al. Perforating granuloma annulare in a patient with acquired immunodeficiency syndrome. Immunohistologic evaluation of the cellular infiltrate. Arch Dermatol 123 (1987) 1217-1220
57. Toro J.R., Chu P., Yen T.S., et al. Granuloma annulare and human immunodeficiency virus infection. Arch Dermatol 135 (1999) 1341-1346
58. McGregor J.M., and McGibbon D.H. Disseminated granuloma annulare as a presentation of acquired immunodeficiency syndrome (AIDS). Clin Exp Dermatol 17 (1992) 60-62
59. Calista D., and Landi G. Disseminated granuloma annulare in acquired immunodeficiency syndrome: case report and review of the literature. Cutis 55 (1995) 158-160
60. Paul M., Cribier B., Heid E., et al. Generalized granuloma annulare and drug-induced immunodeficiency. Ann Dermatol Venereol 131 (2004) 1051-1054
61. Menon Y., Cucurull E., Reisin E., et al. Interferon-alpha-associated sarcoidosis responsive to infliximab therapy. Am J Med Sci 328 (2004) 173-175
62. Fiallo P. Cyclosporin for the treatment of granuloma annulare. Br J Dermatol 138 (1998) 369-370
63. Looney M., and Smith K.M. Isotretinoin in the treatment of granuloma annulare. Ann Pharmacother 38 (2004) 494-497
64. Adams D.C., and Hogan D.J. Improvement of chronic generalized granuloma annulare with isotretinoin. Arch Dermatol 138 (2002) 1518-1519
65. Schleicher S.M., Milstein H.J., Lim S.J., et al. Resolution of disseminated granuloma annulare with isotretinoin. Int J Dermatol 31 (1992) 371-372
66. Hertl M.S., Haendle I., Schuler G., et al. Rapid improvement of recalcitrant disseminated granuloma annulare upon treatment with the tumour necrosis factor-alpha inhibitor, infliximab. Br J Dermatol 152 (2005) 552-555
67. Lynch J.M., and Barrett T.L. Collagenolytic (necrobiotic) granulomas: part II-the "red" granulomas. J Cutan Pathol 31 (2004) 409-418
68. Wee S.A., and Possick P. Necrobiosis lipoidica. Dermatol Online J 10 (2004) 18
69. Boulton A.J., Cutfield R.G., Abouganem D., et al. Necrobiosis lipoidica diabeticorum: a clinicopathologic study. J Am Acad Dermatol 18 (1988) 530-537
70. Kelly W.F., Nicholas J., Adams J., et al. Necrobiosis lipoidica diabeticorum: association with background retinopathy, smoking, and proteinuria. A case controlled study. Diabet Med 10 (1993) 725-728
71. Kavanagh G.M., Novelli M., Hartog M., et al. Necrobiosis lipoidica-involvement of atypical sites. Clin Exp Dermatol 18 (1993) 543-544
72. Verrotti A., Chiarelli F., Amerio P., et al. Necrobiosis lipoidica diabeticorum in children and adolescents: a clue for underlying renal and retinal disease. Pediatr Dermatol 12 (1995) 220-223
73. Patel G.K., and Mills C.M. A prospective open study of topical psoralen-UV-A therapy for Necrobiosis lipoidica. Arch Dermatol 137 (2001) 1658-1660
74. Petzelbauer P, Wolff K, Tappeiner G. Necrobiosis lipoidica: treatment with systemic corticosteroids. Br J Dermatol Jun 1992;126:542-5.
75. Clayton T.H., and Harrison P.V. Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment. Br J Dermatol 152 3 (2005) 581-582
76. Basaria S., and Braga-Basaria M. Necrobiosis lipoidica diabeticorum: response to pentoxiphylline. J Endocrinol Invest 26 (2003) 1037-1040
77. Drosou A., Kirsner R.S., Welsh E., et al. Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J Cutan Med Surg 7 (2003) 382-386
78. Nguyen K., Washenik K., and Shupack J. Necrobiosis lipoidica diabeticorum treated with chloroquine. J Am Acad Dermatol 46 (2002) S34-S36
79. Smith K. Ulcerating necrobiosis lipoidica resolving in response to cyclosporine-A. Dermatol Online J 3 (1997) 2
80. Stinco G., Parlangeli M.E., De Francesco V., et al. Ulcerated necrobiosis lipoidica treated with cyclosporin A. Acta Derm Venereol 83 (2003) 151-153
81. Stanway A, Rademaker M, Newman P. Healing of severe ulcerative necrobiosis lipoidica with cyclosporin. Australas J Dermatol May 2004;45:119-22.
82. Gambichler T., Kreuter A., Freitag M., et al. Clearance of necrobiosis lipoidica with fumaric acid esters. Dermatology 207 (2003) 422-424
83. Kostler E., and Wollina U. Ulcerated necrobiosis lipoidica: a combined treatment approach with dermatosurgery and PUVA. Int J Low Extrem Wounds 2 (2003) 243-245
84. De Rie M.A., Sommer A., Hoekzema R., et al. Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A. Br J Dermatol 147 (2002) 743-747
85. Clayton T.H., and Harrison P.V. Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment. Br J Dermatol 152 (2005) 581-582
86. Ugurlu S., Bartley G.B., and Gibson L.E. Necrobiotic xanthogranuloma: long-term outcome of ocular and systemic involvement. Am J Ophthalmol 129 (2000) 651-657
87. Finan M.C., and Winkelmann R.K. Histopathology of necrobiotic xanthogranuloma with paraproteinemia. J Cutan Pathol 14 (1987) 92-99
88. Russo G.G. Necrobiotic xanthogranuloma with scleroderma. Cutis 70 6 (2002) 311-316
89. Chave T.A., and Hutchinson P.E. Necrobiotic xanthogranuloma with two monoclonal paraproteins and no periorbital involvement at presentation. Clin Exp Dermatol 26 (2001) 493-496
90. Hohenleutner S., Hohenleutner U., Stolz W., et al. Necrobiotic xanthogranuloma with eye involvement. Overview and case report. Hautarzt 46 (1995) 330-334
91. Mehregan D.A., and Winkelmann R.K. Necrobiotic xanthogranuloma. Arch Dermatol 128 (1992) 94-100
92. Venencie P.Y., Le Bras P., Toan N.D., et al. Recombinant interferon alfa-2b treatment of necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol 32 (1995) 666-667
93. Georgiou S., Monastirli A., Kapranos N., et al. Interferon alpha-2a monotherapy for necrobiotic xanthogranuloma. Acta Derm Venereol 79 (1999) 484-485
94. Finelli L.G., and Ratz J.L. Plasmapheresis, a treatment modality for necrobiotic xanthogranuloma. J Am Acad Dermatol 17 (1987) 351-354
95. Hauser C., Schifferli J., and Saurat J.H. Complement consumption in a patient with necrobiotic xanthogranuloma and paraproteinemia. J Am Acad Dermatol 24 (1991) 908-911
96. Chandra S., Finklestein E., and Gill D. Necrobiotic xanthogranuloma occurring within linear morphoea. Australas J Dermatol 43 (2002) 52-54
97. Gomez M.T., Polo A.M., Romero A.M., et al. Rheumatoid nodulosis: report of two cases. J Eur Acad Dermatol Venereol 17 (2003) 695-698
98. Kremer J.M., and Lee J.K. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 29 (1986) 822-831
99. Ahmed S.S., Arnett F.C., Smith C.A., et al. The HLA-DRB1*0401 allele and the development of methotrexate-induced accelerated rheumatoid nodulosis: a follow-up study of 79 Caucasian patients with rheumatoid arthritis. Medicine (Baltimore) 80 (2001) 271-278
100. Langevitz P., Maguire L., and Urowitz M. Accelerated nodulosis during azathioprine therapy. Arthritis Rheum 34 (1991) 123-124
101. Cunnane G., Warnock M., Fye K.H., et al. Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum 47 (2002) 445-449